Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis.

Ceccarelli, M; Pavone, P; Venanzi Rullo, E; Nunnari, G

Ceccarelli, M; Pavone, P; Venanzi Rullo, E; Nunnari, G.

Ceccarelli M; Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Catania, Catania, Italy. emmanuele.venanzirullo@unime.it.

Eur Rev Med Pharmacol Sci ; 25(6): 2473-2474, 2021 03.

Article in English | MEDLINE | ID: covidwho-1172323

Subject(s)

Coronavirus Infections; Coronavirus; Antiviral Agents/therapeutic use; Child; Coronavirus Infections/drug therapy; Humans; Lopinavir/therapeutic use; Ritonavir/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus Infections / Coronavirus Limits: Child / Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2021 Document Type: Article Affiliation country: Eurrev_202103_25408

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google